Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.


Journal

Clinical journal of oncology nursing
ISSN: 1538-067X
Titre abrégé: Clin J Oncol Nurs
Pays: United States
ID NLM: 9705336

Informations de publication

Date de publication:
01 10 2019
Historique:
entrez: 21 9 2019
pubmed: 21 9 2019
medline: 22 9 2020
Statut: ppublish

Résumé

Taxane-induced peripheral neuropathy (TIPN) is caused by the neurotoxicity of paclitaxel and docetaxel, but the differences between paclitaxel- and docetaxel-induced peripheral neuropathy are understudied. The purpose of this study is to compare TIPN between docetaxel and paclitaxel in patients with breast cancer and to examine the consistency of measuring TIPN between researchers and patients. Secondary data were analyzed from a cross-sectional study that included 64 patients with breast cancer from two teaching hospitals in Taiwan. Objective and subjective TIPN were measured. Results indicated significant differences in objective TIPN, sensory sum score, and motor sum score between groups. No significant difference was detected in subjective TIPN between groups.

Sections du résumé

BACKGROUND
Taxane-induced peripheral neuropathy (TIPN) is caused by the neurotoxicity of paclitaxel and docetaxel, but the differences between paclitaxel- and docetaxel-induced peripheral neuropathy are understudied.
OBJECTIVES
The purpose of this study is to compare TIPN between docetaxel and paclitaxel in patients with breast cancer and to examine the consistency of measuring TIPN between researchers and patients.
METHODS
Secondary data were analyzed from a cross-sectional study that included 64 patients with breast cancer from two teaching hospitals in Taiwan. Objective and subjective TIPN were measured.
FINDINGS
Results indicated significant differences in objective TIPN, sensory sum score, and motor sum score between groups. No significant difference was detected in subjective TIPN between groups.

Identifiants

pubmed: 31538967
doi: 10.1188/19.CJON.494-501
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Docetaxel 15H5577CQD
Paclitaxel P88XT4IS4D

Types de publication

Journal Article

Langues

eng

Pagination

494-501

Auteurs

Ya-Ning Chan (YN)

University of North Carolina at Chapel Hill.

You-Wun Jheng (YW)

Taichung Veterans General Hospital.

Pei-Ju Wang (PJ)

National Yang-Ming University Hospital.

Chin-Yau Chen (CY)

National Yang-Ming University Hospital.

Ming-Wei Lin (MW)

National Yang-Ming University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH